The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer

Nature Clinical Practice Urology

Volumn 4, Issue 11, 2007, Pages 605-614

  Skolarus, Ted A ^a   Wolin, Kathleen Y ^a   Grubb III, Robert L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BODY MASS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; HUMAN; LAPAROSCOPIC SURGERY; MALE; OBESITY; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; ROBOTICS; TREATMENT OUTCOME; UNITED STATES;

BODY MASS INDEX; BRACHYTHERAPY; HUMANS; MALE; MASS SCREENING; OBESITY; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 36248931444     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0944     Document Type: Review

References (60)

1. Ogden CL et al. (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555
2. Jemal A et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66
3. Calle EE et al. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638
4. Baillargeon J et al. (2005) The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103: 1092-1095
5. Fowke JH et al. (2006) Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 107: 2361-2367
6. Loeb S et al. (2007) Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 177: 102-106
7. D'Amico AV et al. (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351: 125-135
8. Freedland SJ et al. (2006) Obesity, serum prostate specific antigen and prostate size: Implications for prostate cancer detection. J Urol 175: 500-504
9. Bosch JL et al. (1995) Prostate specific antigen in a community-based sample of men without prostate cancer: Correlations with prostate volume, age, body mass index, and symptoms of prostatism. Prostate 27: 241-249
10. Hutterer G et al. (2007) Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur J Cancer 43: 1180-1187
11. Kristal AR et al. (2006) Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 106: 320-328
12. Ku JH et al. (2003) Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 61: 132-136
13. Dahle SE et al. (2002) Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 168: 599-604
14. Hammarsten J and Högstedt B (2001) Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39: 151-158
15. Putnam SD et al. (2000) Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 10 361-369
16. Andersson SO et al. (1997) Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 89: 385-389
17. Engeland A et al. (2003) Height, body mass index, and prostate cancer: A follow-up of 950,000 Norwegian men. Br J Cancer 89 1237-1242
18. Giovannucci E et al. (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6: 557-563
19. Nilsen TI and Vatten LJ (1999) Anthropometry and prostate cancer risk: A prospective study of 22,248 Norwegian men. Cancer Causes Control 10: 269-275
20. Schuurman AG et al. (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151 541-549
21. Hubbard JS et al. (2004) Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology 63: 253-258
22. Clarke G and Whittemore AS (2000) Prostate cancer risk in relation to anthropometry and physical activity: The National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study. Cancer Epidemiol Biomarkers Prev 9: 875-881
23. MacInnis RJ and English DR (2006) Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis. Cancer Causes Control 17: 989-1003
24. Wright ME et al. (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109: 675-684
25. Gong Z et al. (2006) Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15: 1977-1983
26. Rodriguez C et al. (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16: 63-69
27. Freedland SJ and Platz EA (2007) Obesity and prostate cancer: Making sense out of apparently conflicting data. Epidemiol Rev 29: 88-97
28. Dal Maso L et al. (2004) Prostate cancer and body size at different ages: An Italian multicentre case-control study. Br J Cancer 90: 2176-2180
29. Robinson WR et al. (2005) Obesity before age 30 years and risk of advanced prostate cancer. Am J Epidemiol 161: 1107-1114
30. Fontaine KR et al. (2005) Obesity and prostate cancer screening in the USA. Public Health 119: 694-698
31. Barqawi AB et al. (2005) Observed effect of age and body mass index on total and complexed PSA: Analysis from a national screening program. Urology 65: 708-712
32. Wemy DM et al. (2007) Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16: 70-76
33. Karakiewicz PI et al. (1997) Outcome of sextant biopsy according to gland volume. Urology 49: 55-59
34. Anast JW et al. (2005) The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol 173: 1132-1138
35. Freedland SJ et al. (2005) Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy. Urology 65: 1131-1136
36. Litwin MS et al. (1998) The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36: 1002-1012
37. Montgomery JS et al. (2006) Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy. J Urol 176: 257-261
38. Ahlering TE et al. (2005) Impact of obesity on clinical outcomes in robotic prostatectomy. Urology 65: 740-744
39. Freedland SJ et al. (2004) Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22: 446-453
40. Freedland SJ et al. (2005) Obesity and capsular incision at the time of open retropubic radical prostatectomy. J Urol 174: 1798-1801
41. Amling CL et al. (2004) Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22: 439-445
42. Chang SS et al. (2004) Predicting blood loss and transfusion requirements during radical prostatectomy: The significant negative impact of increasing body mass index. J Urol 171: 1861-1865
43. Hsu EI et al. (2003) Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy. Urology 61: 601-606
44. Yang BK et al. (2006) Radical perineal prostatectomy for treatment of localized prostate cancer in obese and nonobese patients: A matched control study. Urology 67: 990-995
45. Dahm P et al. (2005) Radical perineal prostatectomy for the treatment of localized prostate cancer in morbidly obese patients. J Urol 174: 131-134
46. Eden CG et al. (2006) The impact of obesity on laparoscopic radical prostatectomy. BJU Int 98: 1279-1282
47. Brown JA et al. (2005) Laparoscopic radical prostatectomy and body mass index: An assessment of 151 sequential cases. J Urol 173 442-445
48. El-Feel A et al. (2003) Laparoscopic radical prostatectomy - an analysis of factors affecting operating time. Urology 62: 314-318
49. Singh A et al. (2005) Impact of prostate size and body mass index on perioperative morbidity after laparoscopic radical prostatectomy. J Urol 173: 552-554
50. Bhayani SB et al. (2004) Laparoscopic radical prostatectomy: A multi-institutional study of conversion to open surgery. Urology 63: 99-102
51. Mikhail AA et al. (2006) Robotic-assisted laparoscopic prostatectomy in overweight and obese patients. Urology 67: 774-779
52. Khaira HS et al. (2006) Does obesity influence the operative course or complications of robot-assisted laparoscopic prostatectomy. BJU Int 98: 1275-12788; discussion, 1278
53. Amling CL et al. (2001) Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 58: 723-728
54. Rohrmann S et al. (2003) Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 55: 140-146
55. Mydlo JH et al. (2001) A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate. Prostate Cancer Prostatic Dis 4: 101-105
56. Mallah KN et al. (2005) Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 103: 2030-2034
57. Neugut AI et al. (2004) The 'skinny' on obesity and prostate cancer prognosis. J Clin Oncol 22: 395-398
58. Rockhill J et al. (2002) Prostate brachytherapy in obese patients. Brachytherapy 1: 54-60
59. Merrick GS et al. (2005) Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Urology 65: 95-100
60. Strom SS et al. (2006) Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107: 631-639